Nanobiotix S.A. (EPA:NANO)

Nanobiotix Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	2,139	943	143	313	126	254
Market Cap Growth	1396.34%	558.09%	-54.17%	147.96%	-50.42%	-46.44%
Enterprise Value	2,181	966	126	345	108	203
Last Close Price	44.10	19.50	3.02	6.64	3.62	7.31
PS Ratio	65.62	28.95	-19.93	8.64	26.42	96.13
PB Ratio	-25.31	-11.17	-2.18	-169.73	-4.66	9.50
P/TBV Ratio	-	-	-	-	-	9.50
EV/Sales Ratio	66.92	29.63	-	9.53	22.66	76.63
Debt / Equity Ratio	-1.13	-1.13	-0.77	-27.44	-1.97	1.72
Net Debt / Equity Ratio	-0.50	-0.50	-0.02	13.41	-0.44	-1.41
Net Debt / EBITDA Ratio	-4.06	-4.06	-0.02	1.09	-0.27	0.83
Net Debt / FCF Ratio	-1.25	-1.25	-0.06	1.93	-0.32	1.26
Asset Turnover	0.48	0.48	-	0.47	0.06	0.02
Quick Ratio	1.05	1.05	0.99	1.68	1.23	2.38
Current Ratio	1.09	1.09	1.04	1.75	1.38	2.53
Return on Equity (ROE)	-	-	-	-	-	-96.66%
Return on Assets (ROA)	-10.06%	-10.06%	-52.89%	-19.72%	-35.38%	-25.00%
Return on Capital Employed (ROCE)	-106.10%	-106.10%	-804.70%	-55.10%	-209.40%	-72.60%
Earnings Yield	-1.12%	-2.54%	-47.53%	-12.69%	-45.21%	-18.47%
FCF Yield	-1.59%	-3.60%	-14.23%	-4.09%	-29.48%	-11.83%
Buyback Yield / Dilution	-1.17%	-1.17%	-27.99%	-5.96%	-0.34%	-42.43%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.